Tiziana Life Sciences LTD
Tiziana Life Sciences develops intranasal immunotherapies using alternative drug delivery technologies.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
Tiziana Life Sciences develops intranasal immunotherapies using alternative drug delivery technologies.
November 2026
October 2026
September 2026
August 2026
July 2026